Korean J Gastroenterol.
2013 Jul;62(1):3-26. 10.4166/kjg.2013.62.1.3.
Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Korea, 2013 Revised Edition
- Affiliations
-
- 1Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
- 2Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.
- 3Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
- 4Department of Internal Medicine, Kyung Hee University College of Medicine, Seoul, Korea.
- 5Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. leeyc@yuhs.ac
- 6Center for Gastric Cancer, National Cancer Center, Goyang, Korea.
- 7Department of Internal Medicine, Hallym University College of Medicine, Seoul, Korea.
- 8Department of Preventive Medicine and Public Health, Ajou University School of Medicine, Suwon, Korea.
- 9Steering Committee for Clinical Practice Guideline, Korean Academy of Medical Science, Korea.
- KMID: 1711275
- DOI: http://doi.org/10.4166/kjg.2013.62.1.3
Abstract
- Since the Korean College of Helicobacter and Upper Gastrointestinal Research has first developed the guideline for the diagnosis and treatment of Helicobacter pylori infection in 1998, the revised guideline was proposed in 2009 by the same group. Although the revised guideline was made by comprehensive review of previous articles and consensus of authoritative expert opinions, the evidence-based developmental process was not applied in the revision of the guideline. This new guideline has been revised especially in terms of changes in the indication and treatment of H. pylori infection in Korea, and developed by the adaptation process as evidence-based method; 6 guidelines were retrieved by systematic review and the Appraisal of Guidelines for Research and Evaluation (AGREE) II process, 21 statements were made with grading system and revised by modified Delphi method. After revision, 11 statements for the indication of test and treatment, 4 statements for the diagnosis and 4 statements for the treatment have been developed, respectively. The revised guideline has been reviewed by external experts before the official endorsement, and will be disseminated for usual clinical practice in Korea. Also, the scheduled update and revision of the guideline will be made periodically.
Keyword
MeSH Terms
-
Amoxicillin/therapeutic use
Anti-Bacterial Agents/therapeutic use
Aspirin/therapeutic use
Bismuth/therapeutic use
Breath Tests
Clarithromycin/therapeutic use
Gastroesophageal Reflux/etiology
Gastroscopy
Helicobacter Infections/complications/*diagnosis/drug therapy
*Helicobacter pylori
Humans
Lymphoma, B-Cell, Marginal Zone/complications
Metaplasia/complications
Metronidazole/therapeutic use
Peptic Ulcer/complications/drug therapy
Proton Pump Inhibitors/therapeutic use
Republic of Korea
Stomach Neoplasms/complications/surgery
Tetracycline/therapeutic use
Amoxicillin
Anti-Bacterial Agents
Aspirin
Bismuth
Clarithromycin
Metronidazole
Proton Pump Inhibitors
Tetracycline
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Diagnosis and Treatment of Helicobacter Pylori Infection: Korean and Overseas Guidelines
- Diagnosis of Helicobacter pylori Infection in Children and Adolescents in Korea
- Current Strategies for Eradication of Helicobacter pylori in Korea
- Helicobacter pylori Eradication in Patients Undergoing Gastrectomy: Diagnosis and Therapy
- Web Survey of Society Members' Recognition of Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Korea, 2013 Revised Edition
